Linden Thomas Advisory Services’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.03M Buy
8,364
+224
+3% +$76.7K 0.24% 125
2026
Q1
$2.86M Buy
8,140
+213
+3% +$75.9K 0.28% 106
2025
Q4
$2.59M Buy
7,927
+255
+3% +$80.9K 0.26% 105
2025
Q3
$2.17M Buy
7,672
+257
+3% +$74.5K 0.22% 139
2025
Q2
$2.07M Buy
7,415
+300
+4% +$85K 0.23% 137
2025
Q1
$2.22M Buy
7,115
+52
+0.7% +$15.4K 0.29% 106
2024
Q4
$1.84M Sell
7,063
-28
-0.4% -$8.31K 0.23% 147
2024
Q3
$2.28M Sell
7,091
-24
-0.3% -$7.85K 0.31% 91
2024
Q2
$2.22M Sell
7,115
-99
-1% -$29.1K 0.34% 71
2024
Q1
$2.05M Buy
7,214
+46
+0.6% +$13.5K 0.33% 87
2023
Q4
$2.06M Buy
7,168
+307
+4% +$83.6K 0.39% 60
2023
Q3
$1.84M Buy
6,861
+100
+1% +$25K 0.41% 55
2023
Q2
$1.5M Buy
6,761
+187
+3% +$43.4K 0.33% 99
2023
Q1
$1.59M Buy
6,574
+650
+11% +$160K 0.39% 80
2022
Q4
$1.56M Buy
+5,924
New +$1.59M 0.44% 69

Other funds holding AMGN

Linden Thomas Advisory Services's AMGN Position: Q2 2026 in Review

Linden Thomas Advisory Services increased its Amgen (AMGN) stake by 2.8% in Q2 2026, buying an estimated $76.7K and bringing the position to 8,364 shares worth $3.03M. The position accounts for 0.24% of the portfolio, ranked #125.

Linden Thomas Advisory Services first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Linden Thomas Advisory Services held 8,364 shares of Amgen worth $3.03M as of Q2 2026.
  • Linden Thomas Advisory Services bought 224 Amgen shares in Q2 2026, an estimated $76.7K.
  • Amgen made up 0.24% of Linden Thomas Advisory Services's portfolio in Q2 2026, its #125 holding.
  • Linden Thomas Advisory Services first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Linden Thomas Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.